Jefferies Upgrades BeOne Medicines (ONC) to Buy

July 13, 2026 2:19 AM

Jefferies analyst Faisal Khurshid upgraded BeOne Medicines (NASDAQ: ONC) from Hold to Buy with a price target of $380.00 (from ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found